Zhenhua Chemical Achieves Net Profits of RMB 122 Million in Q1 2026, Up 3.61% Year-on-Year

Zhejiang Medicine Reports Net Profits of RMB 287 Million in Q1 2026, Down 29.84% Year-on-Year

Yifan Pharmaceutical Reports Net Profits of RMB 107 Million in Q1 2026, Down 30.25% Year-on-Year

Brother Enterprises Achieves RMB 35.22 Million Net Profits in Q1 2026, Up 68.47% Year-on-Year

Zhejiang NHU Reports RMB 1.827 Billion Net Profits in Q1 2026, Down 2.80% Year-on-Year

Tianxin Pharmaceutical Reports Net Profits of RMB 147 Million in Q1 2026, Down 32.74% Year-on-Year

ShengDa Biological Reports Net Profits of RMB 13.17 Million in Q1 2026, Down 39.31% Year-on-Year

NengTer Technology Reports Net Profits of RMB 23.71 Million in Q1 2026, Down 89.42% Year-on-Year

Meihua Holdings Group Reports Net Profits of RMB 118 Million in Q1 2026, Down 88.42% Year-on-Year

Kingdomway Group Reports Net Profits of RMB 65.61 Million in Q1 2026, Down 46.11% Year-on-Year